A prospective, randomized and blinded comparison between 10,000 IU urinary and 250 μg recombinant human chorionic gonadotropin for oocyte maturation in in vitro fertilization cycles

Vicente Abdelmassih, Flavio G. Oliveira, Sergio P. Goncalves, Adriana D. Varella, Michael Peter Diamond, Roger Abdelmassih

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: To compare the efficacy and safety of u-hCG with r-hCG in IVF cycles. Methods: A prospective, investigator-blind, randomized, comparative study. Patients (n = 100) ≤35 years with IVF indication were randomly assigned on the day of hCG administration for oocyte maturation to receive either u-hCG (10,000 IU) or r-hCG (250 μ g). Results: No statistical differences were found between groups in relation to total number of oocytes retrieved, percentage of mature oocytes, number of injected oocytes, fertilization rates and number of embryos transferred. The data indicate a possible trend toward a higher incidence of pregnancy in the r-hCG group. Adverse events, predominantly injection-site reactions, were significantly more common in the u-hCG group. Conclusions: r-hCG is at least as effective for inducing final stages of oocyte maturation as 10,000 IU u-hCG and is also associated with significantly better patient tolerance and thus higher patient acceptability.

Original languageEnglish (US)
Pages (from-to)149-153
Number of pages5
JournalJournal of Assisted Reproduction and Genetics
Volume22
Issue number4
DOIs
StatePublished - Apr 1 2005
Externally publishedYes

Fingerprint

Chorionic Gonadotropin
Fertilization in Vitro
Oocytes
Fertilization
Embryonic Structures
Research Personnel
Safety
Pregnancy
Injections
Incidence

Keywords

  • In vitro fertilization
  • Luteinizing hormone
  • Oocyte maturation
  • Recombinant human chorionic gonadotropin
  • Urinary human chorionic gonadotropin

ASJC Scopus subject areas

  • Reproductive Medicine
  • Genetics
  • Obstetrics and Gynecology
  • Developmental Biology
  • Genetics(clinical)

Cite this

A prospective, randomized and blinded comparison between 10,000 IU urinary and 250 μg recombinant human chorionic gonadotropin for oocyte maturation in in vitro fertilization cycles. / Abdelmassih, Vicente; Oliveira, Flavio G.; Goncalves, Sergio P.; Varella, Adriana D.; Diamond, Michael Peter; Abdelmassih, Roger.

In: Journal of Assisted Reproduction and Genetics, Vol. 22, No. 4, 01.04.2005, p. 149-153.

Research output: Contribution to journalArticle

@article{31dad26442fc40b9a036657d22e98a9c,
title = "A prospective, randomized and blinded comparison between 10,000 IU urinary and 250 μg recombinant human chorionic gonadotropin for oocyte maturation in in vitro fertilization cycles",
abstract = "Purpose: To compare the efficacy and safety of u-hCG with r-hCG in IVF cycles. Methods: A prospective, investigator-blind, randomized, comparative study. Patients (n = 100) ≤35 years with IVF indication were randomly assigned on the day of hCG administration for oocyte maturation to receive either u-hCG (10,000 IU) or r-hCG (250 μ g). Results: No statistical differences were found between groups in relation to total number of oocytes retrieved, percentage of mature oocytes, number of injected oocytes, fertilization rates and number of embryos transferred. The data indicate a possible trend toward a higher incidence of pregnancy in the r-hCG group. Adverse events, predominantly injection-site reactions, were significantly more common in the u-hCG group. Conclusions: r-hCG is at least as effective for inducing final stages of oocyte maturation as 10,000 IU u-hCG and is also associated with significantly better patient tolerance and thus higher patient acceptability.",
keywords = "In vitro fertilization, Luteinizing hormone, Oocyte maturation, Recombinant human chorionic gonadotropin, Urinary human chorionic gonadotropin",
author = "Vicente Abdelmassih and Oliveira, {Flavio G.} and Goncalves, {Sergio P.} and Varella, {Adriana D.} and Diamond, {Michael Peter} and Roger Abdelmassih",
year = "2005",
month = "4",
day = "1",
doi = "10.1007/s10815-005-4911-9",
language = "English (US)",
volume = "22",
pages = "149--153",
journal = "Journal of Assisted Reproduction and Genetics",
issn = "1058-0468",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - A prospective, randomized and blinded comparison between 10,000 IU urinary and 250 μg recombinant human chorionic gonadotropin for oocyte maturation in in vitro fertilization cycles

AU - Abdelmassih, Vicente

AU - Oliveira, Flavio G.

AU - Goncalves, Sergio P.

AU - Varella, Adriana D.

AU - Diamond, Michael Peter

AU - Abdelmassih, Roger

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Purpose: To compare the efficacy and safety of u-hCG with r-hCG in IVF cycles. Methods: A prospective, investigator-blind, randomized, comparative study. Patients (n = 100) ≤35 years with IVF indication were randomly assigned on the day of hCG administration for oocyte maturation to receive either u-hCG (10,000 IU) or r-hCG (250 μ g). Results: No statistical differences were found between groups in relation to total number of oocytes retrieved, percentage of mature oocytes, number of injected oocytes, fertilization rates and number of embryos transferred. The data indicate a possible trend toward a higher incidence of pregnancy in the r-hCG group. Adverse events, predominantly injection-site reactions, were significantly more common in the u-hCG group. Conclusions: r-hCG is at least as effective for inducing final stages of oocyte maturation as 10,000 IU u-hCG and is also associated with significantly better patient tolerance and thus higher patient acceptability.

AB - Purpose: To compare the efficacy and safety of u-hCG with r-hCG in IVF cycles. Methods: A prospective, investigator-blind, randomized, comparative study. Patients (n = 100) ≤35 years with IVF indication were randomly assigned on the day of hCG administration for oocyte maturation to receive either u-hCG (10,000 IU) or r-hCG (250 μ g). Results: No statistical differences were found between groups in relation to total number of oocytes retrieved, percentage of mature oocytes, number of injected oocytes, fertilization rates and number of embryos transferred. The data indicate a possible trend toward a higher incidence of pregnancy in the r-hCG group. Adverse events, predominantly injection-site reactions, were significantly more common in the u-hCG group. Conclusions: r-hCG is at least as effective for inducing final stages of oocyte maturation as 10,000 IU u-hCG and is also associated with significantly better patient tolerance and thus higher patient acceptability.

KW - In vitro fertilization

KW - Luteinizing hormone

KW - Oocyte maturation

KW - Recombinant human chorionic gonadotropin

KW - Urinary human chorionic gonadotropin

UR - http://www.scopus.com/inward/record.url?scp=20844455772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20844455772&partnerID=8YFLogxK

U2 - 10.1007/s10815-005-4911-9

DO - 10.1007/s10815-005-4911-9

M3 - Article

VL - 22

SP - 149

EP - 153

JO - Journal of Assisted Reproduction and Genetics

JF - Journal of Assisted Reproduction and Genetics

SN - 1058-0468

IS - 4

ER -